Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), M. Asselman(Boehringer Ingelheim (Finland)), Jameel Ahmed, Jorge Antonio Aldrete Velasco, Paul Ainsworth(Manchester Metropolitan University), Fabrizio Ammirati, Giorgio Annoni, Dimitrios Alexopoulos(Hygeia Hospital), Chander Arora, Allessandro Aiello, Milla Thompson(Boehringer Ingelheim (Finland)), Fernando Alfonso Manterola, W. Amara(Inserm), Menno V. Huisman(Leiden University Medical Center), Lisa Alderson, Sabrina Marler(Boehringer Ingelheim (United States)), Christine Teutsch(Boehringer Ingelheim (Germany)), Brian Olshansky(Mercy Medical Center), M. Kevin Ariani, Hans‐Christoph Diener(University of Birmingham), David Alonso–Gutiérrez(Universidad de Salamanca), Sebastien Arméro(Hôpital de la Timone), Nima Amjadi, Pedro Adragão(Hospital de Santa Cruz), Jorge Roberto Aiub, Sergio Agosti, Dzifa Wosornu Abban, Srinivas Addala, Muhammad Shakil Aslam, Raed Al-Dallow, Juan Carlos Arias, Piergiuseppe Agostoni(University of Milan), Walter Ageno(University of Padua), Venkatesh Kumar Gurusamy(Boehringer Ingelheim (Germany)), Nabil Andrawis, Francisco Aguilar(Jefferson Einstein Philadelphia Hospital), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Gerardo Ansalone(Ospedale San Filippo Neri), Pareed Aliyar, Rajesh Aggarwal(Southend University Hospital NHS Foundation Trust), Fernando Costa, Luis Aguinaga(Centro Científico Tecnológico - Tucumán), Mathieu Amelot, Gregory Y H Lip(University of Liverpool), Nasser Abdul, José Amado(Universidad de Cantabria), Marianna Andrade, Julio Aguilar Linares, Atilio Marcelo Abud, Fran Adams
Hellenic Journal of Cardiology
December 16, 2020
Cited by 3


Related Papers